Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$0.14 - $0.26 $28 - $52
200 New
200 $0
Q3 2023

Nov 13, 2023

SELL
$0.76 - $1.16 $126 - $192
-166 Reduced 76.85%
50 $0
Q1 2023

May 12, 2023

BUY
$0.94 - $2.02 $47 - $101
50 Added 30.12%
216 $0
Q1 2022

May 04, 2022

SELL
$2.65 - $4.84 $2 - $4
-1 Reduced 0.6%
166 $1,000
Q3 2021

Nov 05, 2021

BUY
$5.23 - $8.89 $5 - $8
1 Added 0.6%
167 $1,000
Q2 2021

Aug 02, 2021

SELL
$7.12 - $9.15 $946 - $1,216
-133 Reduced 44.48%
166 $1,000
Q1 2021

May 13, 2021

BUY
$6.81 - $9.64 $905 - $1,282
133 Added 80.12%
299 $2,000
Q1 2020

May 18, 2020

BUY
$3.71 - $6.05 $615 - $1,004
166 New
166 $1,000

Others Institutions Holding SNOA

# of Institutions
1
Shares Held
2.27K
Call Options Held
0
Put Options Held
0

About Sonoma Pharmaceuticals, Inc.


  • Ticker SNOA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,100,940
  • Market Cap $8.19M
  • Description
  • Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription ...
More about SNOA
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.